STOCK TITAN
  1. Home
  2. News
  3. MLSS

Milestone Scientific, Inc. - MLSS STOCK NEWS

Welcome to our dedicated page for Milestone Scientific news (Ticker: MLSS), a resource for investors and traders seeking the latest updates and insights on Milestone Scientific stock.

Milestone Scientific, Inc. (NASDAQ: MLSS) is a pioneering company in the field of medical and dental anesthesia. The company focuses on the development, manufacture, marketing, and sale of computer-controlled local anesthetic delivery (C-CLAD) systems designed to provide improved and painless local anesthetic delivery. These systems are marketed under various trademarks for different applications. For dentistry, the products are known as CompuDent™ and STA™ (Single Tooth Anesthesia) System. These innovative devices allow for painless injections during a wide range of dental procedures, from routine cleanings to complex surgeries involving implants, root canals, and crowns.

For medical applications, Milestone Scientific offers similar technology under the CompuMed™ trademark. Their products are used across various medical disciplines, including plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, and orthopedics. The company's advanced anesthetic delivery systems are sold both in the United States and in over 25 countries worldwide, highlighting their global reach and impact.

Besides their core product offerings, Milestone Scientific also provides The Wand™, a handpiece that allows for almost painless injections, enhancing patient comfort significantly.

The firm's operations are divided into two main segments: Dental and Medical. Geographically, all operations are concentrated in the United States, but their products are influential on a global scale.

Recent Achievements:

  • Successful evaluations by prominent medical professionals, such as Dr. Matthew Stottle of Omaha Pain Physicians, achieving 100% success rates.
  • Acceleration in reimbursement claims submission for the CompuFlo® Epidural System.

For more information or inquiries, Milestone Scientific can be contacted through Crescendo Communications, LLC via email at mlss@crescendo-ir.com or by phone at 212-671-1020.

News

Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update

Rhea-AI Summary
Milestone Scientific Inc. (MLSS) reports initial reimbursements of CompuFlo® by commercial payors and Medicare. The CEO, Arjan Haverhals, updates shareholders on the successful commercialization of the CompuFlo technology and the positive traction it has gained. The company has received FDA clearance for expanded use of the technology and has launched a reimbursement plan to support pain management providers. The advisory sites implementing CompuFlo technology have reported a 100% success rate for patient procedures, with zero dural punctures. The University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital has expanded the use of CompuFlo beyond the labor and delivery department, demonstrating the positive clinical feedback received. The company is focused on increasing the number of CompuFlo providers in the US and accelerating patient access to the technology through ongoing education and engagement with payors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
none
-
News

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock

Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) closed a public offering of 4,765,000 shares of common stock at $0.63 per share, generating approximately $3.0 million in gross proceeds. The underwriter has a 45-day option to purchase up to an additional 714,750 shares. The Offering was disclosed in a final prospectus supplement on December 12, 2023, following the registration statement's effectiveness on October 30, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
offering
-
News

Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock

Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) has announced the pricing of an underwritten public offering of 4,765,000 shares of its common stock at a price of $0.63 per share, expected to generate approximately $3.0 million in gross proceeds. The Offering is expected to close on December 13, 2023, with Maxim Group LLC acting as the sole book-runner. The Company has also granted the underwriter a 45-day option to purchase up to an additional 714,750 shares of common stock on the same terms and conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.68%
Tags
offering
News

Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock

Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) has commenced an underwritten public offering of shares of its common stock, with an option to purchase additional shares. Maxim Group LLC is acting as the sole book-runner for the Offering. The Offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-275088) previously filed with the U.S. Securities and Exchange Commission ('SEC').
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.68%
Tags
offering
-
News

Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures

Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) has commenced commercial sales of CompuFlo® disposables for use in neurostimulation spinal cord stimulator implantation procedures at the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital, following a successful evaluation process by Dr. Patrick Karas, MD, with 100% success rate and no complications. This expansion of use within the institution showcases the potential of CompuFlo® in improving patient outcomes and lowering costs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.13%
Tags
none
-
News

Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain

Rhea-AI Summary
Milestone Scientific Inc. (MLSS) has entered into an agreement with Bioline Supply to distribute the CompuFlo® Epidural System and related disposables in Spain. This partnership aims to provide pain clinics and hospitals in Spain with access to Milestone Scientific's innovative technology, enhancing the safety and predictability of epidural procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
none
News

Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023

Rhea-AI Summary
Milestone Scientific Inc. (NYSE: MLSS) reports a 45% increase in domestic sales for the third quarter of 2023, along with a new online store, higher gross profit margin, and expansion in the medical division. The company also made progress in advancing the reimbursement strategy for the CompuFlo® Epidural System.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News

Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) to host conference call to discuss Q3 financial results and corporate progress, accessible via phone and webcast
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.11%
Tags
earnings
-
News

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York

Rhea-AI Summary
Milestone Scientific Inc. (NYSE:MLSS) has started selling CompuFlo® Epidural disposables to Island Ambulatory Surgery Center, affiliated with Mount Sinai Health System, marking the company's entry into the ambulatory surgery center market. The founder and medical director, Dr. Leon Reyfman, reported 100% success in the evaluation of the system, praising its potential to transform drug delivery in pain management and anesthesiology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.41%
Tags
none
News

Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors

Rhea-AI Summary
Milestone Scientific appoints Dr. Didier Demesmin to Board of Directors, expects CompuFlo Epidural System to become standard of care in epidural analgesia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
management

FAQ

What is the current stock price of Milestone Scientific (MLSS)?

The current stock price of Milestone Scientific (MLSS) is $0.678 as of November 20, 2024.

What is the market cap of Milestone Scientific (MLSS)?

The market cap of Milestone Scientific (MLSS) is approximately 51.0M.

What does Milestone Scientific, Inc. do?

Milestone Scientific develops, manufactures, markets, and sells computer-controlled local anesthetic delivery systems for medical and dental applications.

What are the main products offered by Milestone Scientific?

The main products include CompuDent™, STA™ System, CompuMed™, and The Wand™, catering to various dental and medical procedures.

Where are Milestone Scientific’s products sold?

Their products are sold in the United States and in over 25 countries worldwide.

What recent achievements has Milestone Scientific accomplished?

Recent achievements include a 100% success rate in evaluations by Dr. Matthew Stottle and accelerated reimbursement claims for the CompuFlo® Epidural System.

What are the main segments of Milestone Scientific’s business?

The two main segments are Dental and Medical.

How can Milestone Scientific be contacted?

They can be contacted through Crescendo Communications, LLC via email at mlss@crescendo-ir.com or by phone at 212-671-1020.

What is The Wand™?

The Wand™ is a handpiece provided by Milestone Scientific that enables dentists to deliver painless injections for various dental procedures.

What is the STA™ System?

The STA™ System is the Single Tooth Anesthesia system suitable for all dental procedures, marketed under Milestone Scientific’s portfolio.

Which medical disciplines use Milestone Scientific’s systems?

Their systems are used in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics, and other disciplines.

What is CompuMed™?

CompuMed™ is the trademark under which Milestone Scientific markets its computer-controlled anesthetic delivery systems for medical applications.

Stock MLSS logo
Milestone Scientific, Inc.

NYSE:MLSS

MLSS Rankings

#4815 Ranked by Market Cap
N/A Ranked by Dividends

MLSS Stock Data

51.02M
65.92M
15.5%
5.47%
0.15%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
LIVINGSTON